Whan In Pharm Co.,Ltd. Statistics
Total Valuation
Whan In Pharm Co.,Ltd. has a market cap or net worth of KRW 186.26 billion. The enterprise value is 135.23 billion.
Market Cap | 186.26B |
Enterprise Value | 135.23B |
Important Dates
The last earnings date was Thursday, November 14, 2024.
Earnings Date | Nov 14, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Whan In Pharm Co.,Ltd. has 15.27 million shares outstanding. The number of shares has increased by 0.02% in one year.
Current Share Class | n/a |
Shares Outstanding | 15.27M |
Shares Change (YoY) | +0.02% |
Shares Change (QoQ) | -0.05% |
Owned by Insiders (%) | 28.36% |
Owned by Institutions (%) | 19.01% |
Float | 10.94M |
Valuation Ratios
The trailing PE ratio is 6.81 and the forward PE ratio is 9.24.
PE Ratio | 6.81 |
Forward PE | 9.24 |
PS Ratio | 0.74 |
PB Ratio | 0.50 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.79, with an EV/FCF ratio of -32.48.
EV / Earnings | 4.94 |
EV / Sales | 0.54 |
EV / EBITDA | 3.79 |
EV / EBIT | 4.86 |
EV / FCF | -32.48 |
Financial Position
The company has a current ratio of 4.54, with a Debt / Equity ratio of 0.00.
Current Ratio | 4.54 |
Quick Ratio | 3.01 |
Debt / Equity | 0.00 |
Debt / EBITDA | 0.01 |
Debt / FCF | -0.12 |
Interest Coverage | 1,265.78 |
Financial Efficiency
Return on equity (ROE) is 7.55% and return on invested capital (ROIC) is 4.66%.
Return on Equity (ROE) | 7.55% |
Return on Assets (ROA) | 4.15% |
Return on Capital (ROIC) | 4.66% |
Revenue Per Employee | 432.52M |
Profits Per Employee | 47.02M |
Employee Count | 582 |
Asset Turnover | 0.62 |
Inventory Turnover | 2.65 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.09% in the last 52 weeks. The beta is 0.17, so Whan In Pharm Co.,Ltd.'s price volatility has been lower than the market average.
Beta (5Y) | 0.17 |
52-Week Price Change | -15.09% |
50-Day Moving Average | 13,256.60 |
200-Day Moving Average | 14,131.25 |
Relative Strength Index (RSI) | 26.92 |
Average Volume (20 Days) | 16,992 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Whan In Pharm Co.,Ltd. had revenue of KRW 251.73 billion and earned 27.36 billion in profits. Earnings per share was 1,792.04.
Revenue | 251.73B |
Gross Profit | 96.27B |
Operating Income | 27.03B |
Pretax Income | 31.57B |
Net Income | 27.36B |
EBITDA | 34.91B |
EBIT | 27.03B |
Earnings Per Share (EPS) | 1,792.04 |
Balance Sheet
The company has 51.53 billion in cash and 506.64 million in debt, giving a net cash position of 51.02 billion or 3,342.09 per share.
Cash & Cash Equivalents | 51.53B |
Total Debt | 506.64M |
Net Cash | 51.02B |
Net Cash Per Share | 3,342.09 |
Equity (Book Value) | 374.16B |
Book Value Per Share | 24,522.23 |
Working Capital | 155.20B |
Cash Flow
In the last 12 months, operating cash flow was 31.28 billion and capital expenditures -35.44 billion, giving a free cash flow of -4.16 billion.
Operating Cash Flow | 31.28B |
Capital Expenditures | -35.44B |
Free Cash Flow | -4.16B |
FCF Per Share | -272.70 |
Margins
Gross margin is 38.24%, with operating and profit margins of 10.74% and 10.87%.
Gross Margin | 38.24% |
Operating Margin | 10.74% |
Pretax Margin | 12.54% |
Profit Margin | 10.87% |
EBITDA Margin | 13.87% |
EBIT Margin | 10.74% |
FCF Margin | -1.65% |
Dividends & Yields
This stock pays an annual dividend of 300.00, which amounts to a dividend yield of 2.44%.
Dividend Per Share | 300.00 |
Dividend Yield | 2.44% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 16.74% |
Buyback Yield | -0.02% |
Shareholder Yield | 2.41% |
Earnings Yield | 14.69% |
FCF Yield | -2.24% |
Stock Splits
The last stock split was on April 14, 2010. It was a forward split with a ratio of 2.
Last Split Date | Apr 14, 2010 |
Split Type | Forward |
Split Ratio | 2 |
Scores
Whan In Pharm Co.,Ltd. has an Altman Z-Score of 5.11.
Altman Z-Score | 5.11 |
Piotroski F-Score | n/a |